ETHK Labs Inc. Announces Results of Extraordinary General Meeting: Key Resolutions Approved
Hong Kong, 27 July 2026 – ETHK Labs Inc. (Stock Code: 1931), a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange, has released the poll results from its Extraordinary General Meeting (EGM) held on 27 July 2026. The meeting addressed several substantial resolutions regarding significant share transfer agreements and voting rights arrangements, all of which were passed by a narrow margin.
Key Highlights from the EGM
- All Proposed Resolutions Passed: Three major resolutions were put to vote and each secured approval with just over 51% of the votes cast in favor.
- Share Transfer Agreement Ratified: The EGM approved the Share Transfer Agreement dated 12 November 2025 between Hangzhou Better Smart Investment Management Consulting Partnership (the “Purchaser”) and Mr. Ge Hang (the “Vendor”). This agreement, and all related transactions, were confirmed, approved, and ratified.
-
Voting Rights Entrusted Agreements Approved:
- First Voting Rights Entrusted Agreement: Dated 12 November 2025, between the Purchaser and the Vendor, this arrangement concerning the entrustment of voting rights was approved and ratified.
- Second Voting Rights Entrusted Agreement: Dated 14 November 2025, between the Purchaser and Jinfuyuan (Hainan) Private Equity Fund Management Partnership. This agreement and all associated transactions were also confirmed and approved.
- Voting Results: Each resolution received 468,008,858 votes in favor (51.34%) and 443,654,371 votes against (48.66%), indicating a closely divided shareholder base.
- Authorized Actions: Directors of the company have been empowered to take all necessary actions to give effect to these agreements and related transactions.
Important Information for Shareholders
- No Restrictions or Abstentions: There were no restrictions on any shareholders regarding voting, and no shareholders were required to abstain or stated an intention to vote against or abstain. All shares (excluding 17,199,000 treasury shares) were entitled to vote, with a total of 1,604,289,096 shares eligible.
- Full Board Attendance: All directors participated in the EGM either in person or via electronic means.
- Third-party Scrutineer: Tricor Investor Services Limited served as the scrutineer for the vote count, ensuring transparency and accuracy in the poll results.
Potential Price-Sensitive Implications
- The approval of these share transfer and voting rights agreements could have a significant impact on the company’s ownership structure and governance. The close voting margin highlights a divided shareholder base and signals potential shifts in control or influence within ETHK Labs Inc.
- Investors should closely monitor further disclosures regarding the implementation of these agreements, as changes in control or major transactions may influence strategic decisions and, consequently, the share price.
Board Composition
As of the date of the announcement, the Board comprises three executive directors (Mr. Lin Xianya, Mr. Chan Siu Kei Ken, Ms. Yi Xiao), two non-executive directors (Ms. Yao Haiyun, Mr. Liu Fei), and three independent non-executive directors (Dr. Zhong Renqian, Mr. Xu Da, Mr. Zhang Jianlei).
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should seek professional advice before making any investment decisions. The information is based on official company disclosures and may be subject to change.
ETHK Labs Inc. 公佈特別股東大會投票結果：重大決議案獲通過
香港，2026年7月27日 ─ 於香港聯交所上市、於開曼群島註冊成立的ETHK Labs Inc.（股份代號：1931），已公佈2026年7月27日舉行之特別股東大會（EGM）投票結果。會上多項涉及重大股份轉讓及表決權委託協議的決議案均以些微優勢獲通過。
會議重點摘要
- 所有決議案均獲通過： 會上三項主要決議案均獲超過51%股東支持通過。
- 股份轉讓協議獲批： 特別大會批准2025年11月12日由杭州倍特智慧投資管理諮詢合夥企業（“買方”）與葛航先生（“賣方”）簽訂的股份轉讓協議及相關交易。
-
表決權委託協議獲批：
- 第一份表決權委託協議： 2025年11月12日由買方與賣方訂立，關於表決權委託的安排獲得批准及追認。
- 第二份表決權委託協議： 2025年11月14日由買方與金富源（海南）私募基金管理合夥企業訂立，該協議及相關交易同樣獲得確認及批准。
- 投票結果： 各決議案獲得468,008,858票（51.34%）贊成，443,654,371票（48.66%）反對，顯示股東意見分歧明顯。
- 授權董事行動： 董事獲授權採取一切必要措施以落實有關協議及相關交易。
股東需注意的重要事項
- 無投票限制或棄權： 所有股東均無投票限制，亦無股東需根據上市規則棄權或表示將投反對票或棄權。除庫藏股外（17,199,000股），所有股份（共1,604,289,096股）均有投票權。
- 全體董事出席： 所有董事均親身或透過電子方式參與會議。
- 第三方監票： 由卓佳證券登記有限公司擔任監票人，確保投票結果公正準確。
潛在股價敏感影響
- 這些股份轉讓及表決權委託協議獲批，或會對公司股權結構及管治產生重大影響。投票結果接近，反映公司股東立場分歧，或預示公司控制權或影響力將出現變化。
- 投資者應密切留意協議執行情況，因控制權變動或重大交易可能影響公司策略及股價。
董事會組成
截至本公告日期，董事會由三位執行董事（林賢亞先生、陳紹基先生、易曉女士）、兩位非執行董事（姚海雲女士、劉飛先生）及三位獨立非執行董事（鍾仁謙博士、徐達先生、張建磊先生）組成。
免責聲明： 本文僅供資訊參考，並不構成任何投資建議。投資者應在作出任何投資決定前諮詢專業意見。以上內容基於公司官方披露資料，資料或會變更。
